Skip to main content

news

 

A&O Shearman is advising IHH Healthcare, an operator of private hospitals in Asia, on its $900 million acquisition of Island Hospital in Penang from Affinity Equity Partners.

The transaction is expected to close in November 2024 and is one of the largest M&A deals in Malaysia this year. 

"The proposed acquisition will enable IHH to consolidate and solidify its presence in Penang and strengthen its competitive position across Malaysia," IHH said in a stock exchange filing.

IHH said it will also gain a larger share of medical travel into Malaysia, as Island Hospital is the leading hospital for medical tourism, attracting one in three inbound foreign patients to Malaysia, Reuters reported.

The deal “illustrates the ongoing strength of healthcare M&A in the ASEAN region. Hospitals, clinics, and other healthcare infrastructure have been among the most attractive targets for M&A in the last few years and we have continued to support clients looking to gain exposure to this asset class,” said James Mythen, A&O Shearman partner, in a statement.

The A&O Shearman team was led by Mythen and senior associate Felicia Tan, with support from Purita Thanachoksopon and James Chen.

The core team was further supported by a multidisciplinary transaction team across the firm’s global network, including Ka Sen Wong, Jessica Bowring, Jessica Dye, Tze Siong Ang, Richele Suwita, Michael Benedict, Matthew Del Roso, Ang Yu Jia, Kimberly Lee and Nick Ognibene. 

 

TO CONTACT EDITORIAL TEAM, PLEASE EMAIL ALBEDITOR@THOMSONREUTERS.COM

Related Articles

Cleary, A&O Shearman advise on Goodyear's $701 mln Dunlop sale

Cleary Gottlieb has advised tyremaker Goodyear Tire & Rubber Company on the $701 million sale of its Dunlop brand to Japan's Sumitomo Rubber Industries (SRI), which was represented by A&O Shearman.

Mori Hamada, Nagashima Ohno advise on $1.6 bln bid for Fujitsu General

Japanese law firms Mori Hamada & Matsumoto and Nagashima Ohno & Tsunematsu are playing key roles in Paloma Rheem Holdings' 257 billion yen ($1.6 billion) offer to acquire air conditioner manufacturer Fujitsu General.

CAM, Khaitan, Linklaters act on $355 mln Sai Life Sciences IPO

by Nimitt Dixit |

Cyril Amarchand Mangaldas has driven the $355 million initial public offering of TPG-backed Indian healthcare R&D firm Sai Life Sciences, with Khaitan & Co and Linklaters advising the bookrunning lead managers. CAM has also acted for selling promoter shareholders Sai Quest Syn.